FORT MYERS — NeoGenomics says it has agreed to acquire rival cancer-testing laboratory Clarient, a unit of GE Healthcare Life Sciences, in a $275 million deal.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition